Royal Philips (NYSE:PHG) reported quarterly earnings of €0.25 per share. This is a 37.5 percent decrease over earnings of €0.40 per share from the same period last year. The company reported €4.31 billion in sales this quarter. This is a 3.71 percent increase over sales of €4.16 billion the same period last year.
Chardan Capital Maintains Buy on Taysha Gene Therapies, Lowers Price Target to $16
Chardan Capital analyst Geulah Livshits maintains Taysha Gene Therapies (NASDAQ:TSHA) with a Buy and lowers the price target from $32 to $16.
